Skip to main content
Clinical Trials/ISRCTN28898435
ISRCTN28898435CompletedNot Applicable

Does fluid administration in the terminally ill reduce the frequency and amount of sedation required for the management of agitation/restlessness?

HS R&D Regional Programme Register - Department of Health (UK)0 sites0 target enrollmentStarted: January 23, 2004Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Patients who meet the inclusion criteria will be identified during the daily team meetings held within each of the hospices. The inclusion criteria are as follows:
  • 1. Deemed to have a short life expectancy (Bozetti 1996)
  • 2. Aged above 18
  • 3. Inpatient within Butterick Hospice, Teesside Hospice, Hartlepool Hospice, St Oswalds Hospice or the Newcastle Marie Curie Centre
  • 4. Oral intake has fallen below 1000 ml/24 hour and is recognised by the team as part of their deterioration

Exclusion Criteria

  • 1. Known to have cerebral oedema
  • 2. Known to have congestive cardiac failure
  • 3. Known to have a coagulation disorder
  • 4. Known to be in renal or liver failure or are hypercalcaemic
  • 5. Known to have a tumour which has a direct influence on fluid balance

Investigators

Sponsor
HS R&D Regional Programme Register - Department of Health (UK)

Similar Trials